BOSTON SCIENTIFIC CORPORATION Gain (Loss) on Disposition of Business
BOSTON SCIENTIFIC CORPORATION (BSX) reported Gain (Loss) on Disposition of Business of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfBusiness · last filed 2025-02-18
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for the quarter ending 2022-12-31 was -$22.00M, a 173.33% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for fiscal 2024 was $0.00.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for fiscal 2023 was $0.00.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for fiscal 2022 was -$22.00M, a 128.21% decline from fiscal 2021.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on disposition of business for fiscal 2021 was $78.00M.
| Period end | Gain (Loss) on Disposition of Business 3 month | Gain (Loss) on Disposition of Business 6 month | Gain (Loss) on Disposition of Business 9 month | Gain (Loss) on Disposition of Business 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2022-12-31 | -$22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$22.00M derived: sum of 2 quarters · filed 2025-02-18 | -$22.00M derived: sum of 3 quarters · filed 2025-02-18 | -$22.00M 10-K · filed 2025-02-18 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $30.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $30.00M derived: sum of 3 quarters · filed 2024-02-20 | $70.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $30.00M derived: sum of 2 quarters · filed 2024-02-20 | $70.00M derived: sum of 3 quarters · filed 2024-02-20 | $72.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $70.00M derived: sum of 2 quarters · filed 2024-02-20 | $72.00M derived: sum of 3 quarters · filed 2024-02-20 | $78.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $40.00M 10-Q · filed 2022-11-03 | $42.00M derived: sum of 2 quarters · filed 2022-11-03 | $48.00M 10-Q · filed 2022-11-03 | $48.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.00M 10-Q · filed 2022-08-04 | $9.00M 10-Q · filed 2022-08-04 | $8.00M derived: sum of 3 quarters · filed 2023-02-23 | $8.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $6.00M 10-Q · filed 2022-05-05 | $6.00M derived: sum of 2 quarters · filed 2023-02-23 | $6.00M derived: sum of 3 quarters · filed 2023-02-23 | $6.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |